This proposal aims to define the genome-wide chromatinaccessibility landscape of CD8 T cells in Alzheimer’s disease. It is hypothesized that antigen-experienced CD8 T cells contribute to disease via effector-driven antigen control that will be reflected by uncovering specific regions of accessible chromatin. Specifically, we expect to uncover pro-inflammatory genes such as cytokines, chemokines and cytotoxic molecules that will implicate CD8 T cells in AD neuroinflammation. These experiments could elucidate the mechanism by which T cells contribute to AD pathogenesis and may reveal novel immunotherapeutic targets for AD.
|Effective start/end date||2/21/22 → 2/20/24|
- Alzheimer's Disease Research Foundation (AGMT 1/27/23)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.